MRI Surveillance for Brain Metastases from Lung Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this research is to see if monitoring the brain using magnetic resonance imaging (MRI) after radiation therapy will allow investigators to find cancer that has spread to the brain (brain metastases) before it causes symptoms.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is MRI of the brain safe for humans?
How does MRI surveillance for brain metastases from lung cancer differ from other treatments?
Who Is on the Research Team?
Michael K. Farris
Principal Investigator
Wake Forest Baptist Comprehensive Cancer Center
Are You a Good Fit for This Trial?
This trial is for adults over 18 with non-squamous locally advanced lung cancer (stages IIIA-IIIC). They must have started radiation therapy within the past 120 days and be able to undergo MRI scans. Pregnant or breastfeeding individuals, those with known brain metastases, or women of childbearing potential not on contraception are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Radiation Therapy
Participants receive curative intent radiation therapy
Surveillance MRI
Participants undergo scheduled brain MRI to monitor for brain metastases
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- MRI of the Brain
MRI of the Brain is already approved in European Union, United States, Canada, Japan, China, Switzerland for the following indications:
Find a Clinic Near You
Who Is Running the Clinical Trial?
Wake Forest University Health Sciences
Lead Sponsor
National Cancer Institute (NCI)
Collaborator